All Stocks/Consumer Defensive/KVUE

Kenvue Inc.

KVUE
Consumer DefensiveHousehold & Personal Products Website
Ask about KVUEAI research agent
Alpha Score BreakdownHow it works →

Alpha Score of 46 reflects weak overall profile with poor momentum, strong value. Based on 2 of 4 signals — score is capped at 75 until remaining data ingests.

Momentum
30
Poor
Value
98
Strong
Quality
no data
Sentiment
no data
Key StatisticsUpdated Apr 15
P/E Ratio
5.54
Forward P/E
PEG Ratio
EPS (TTM)
3.14
Dividend Yield
Beta
Revenue (TTM)
Net Margin
ROE
Debt / Equity
52W High
$24.44
52W Low
$14.11
About Kenvue Inc.

Kenvue Inc. is the world's largest pure-play consumer health company, specializing in science-backed products for everyday care needs. It operates through three key segments: Self Care, offering cough, cold, allergy, pain, digestive health, smoking cessation, and eye care under brands like Tylenol, Motrin, Benadryl, Nicorette, and Zyrtec; Skin Health and Beauty, providing face, body, hair, sun, and other care items via Neutrogena, Aveeno, Rogaine, and OGX; and Essential Health, delivering oral, baby, women's health, wound care, and related products through Listerine, Johnson's, Band-Aid, and Stayfree. Kenvue serves consumers in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America, focusing on trusted, iconic brands that support daily rituals and critical moments with innovation rooted in clinical research and consumer insights. Incorporated in 2022 and headquartered in Summit, New Jersey, Kenvue emphasizes integrity, quality, and solutions endorsed by healthcare professionals across diverse categories like pain relief, skin care, and oral health.

CEO
Mr. Kirk L. Perry
Employees
21,780
Quick Facts
Exchange
SectorConsumer Defensive
IndustryHousehold & Personal Products
Market Cap
Key Dates

Earnings calendar coming soon. Subscribe to get notified when KVUE reports next.

Get earnings alerts →